COVID-19 Vaccine for Children: 2026 Parent Guide

COVID-19 vaccination recommendations for children have changed since pediatric vaccination campaigns first began. The vaccines available, priority groups, and number of doses are no longer the same as they were in 2022.

If you are considering vaccination for your child, avoid relying on outdated schedules or assuming that every child needs the same number of doses. The decision should take into account your child’s age, medical history, previous vaccinations, prior COVID-19 infections, and the current recommendations in Mexico.

This guide explains what families should know in 2026 and when it may be helpful to speak with a pediatrician.

COVID-19 continues to circulate, although population immunity and the behavior of the virus have changed. Most children experience mild or moderate illness, but some can develop severe disease, require hospitalization, or experience complications.

The risk may be higher in children with:

• Obesity or diabetes
• Moderate or severe asthma
• Chronic lung disease
• Congenital heart disease
• Neurological, genetic, or metabolic conditions
• Kidney disease
• Cancer
• A history of organ transplantation
• A weakened immune system
• Treatments that suppress the immune system

A history of premature birth may also be relevant during the first years of life. International guidance recommends that parents discuss the potential benefits and risks of vaccination with their child’s healthcare provider, particularly when the child has a condition associated with severe COVID-19. CDC:COVID-19 risk factors.

COVID-19 Vaccination for Children in Mexico
Mexico’s 2025–2026 winter vaccination campaign prioritized people at greater risk of complications. These groups included older adults, pregnant women, healthcare workers, and people between 5 and 59 years of age with certain underlying health conditions.

That campaign ran from October 13, 2025, through April 3, 2026. Families seeking vaccination outside that period should confirm current eligibility, vaccine availability, and local recommendations with the appropriate health authorities or medical institutions.

As of July 2026, a 2026–2027 vaccination schedule should not be presented as definitive until Mexico’s Ministry of Health publishes its corresponding seasonal guidelines.

In Mexico, the authorized age range, available vaccine, and required number of doses may change. Families should consult:

• The child’s National Health Card
• Current guidelines from Mexico’s Ministry of Health
• Vaccine authorizations issued by COFEPRIS
• The child’s previous COVID-19 vaccination records
• Availability through local healthcare institutions
• Their pediatrician’s recommendation

Vaccination schedules published in the United States can be useful scientific references, but they should not automatically be applied in Mexico.

There is no single number of doses that applies to every child.

The appropriate schedule may depend on:

• The child’s age on the day of vaccination
• The COVID-19 vaccines previously received
• The date of the most recent dose
• The vaccine authorized and available for the child’s age
• Whether the child is moderately or severely immunocompromised
• Mexico’s current seasonal guidelines

As an international reference, the United States’ 2025–2026 guidance uses different schedules for children ages 6 to 23 months, ages 2 to 4 years, and ages 5 to 11 years. It also provides modified schedules for immunocompromised patients.

This is why an old recommendation stating that every child needs two doses is no longer appropriate. CDC: 2025–2026 COVID-19 vaccination guidance.

Bring your child’s vaccination card and any COVID-19 vaccination records to the appointment, even if previous doses were administered in another city or country.

No. A vaccinated child can still become infected and transmit the virus.

Protection against infection can decrease over time and may change as new variants appear. The primary purpose of vaccination is to reduce the risk of severe illness, hospitalization, and complications, particularly in children with underlying risk factors.

Vaccination also does not replace reasonable preventive measures when a child is sick or lives with someone who is medically vulnerable.

Yes. A previous COVID-19 infection does not prevent a child from being vaccinated later. Infection produces an immune response, but that protection is neither complete nor permanent.

A negative test is not universally required before vaccination. The child should first recover from the acute illness and follow the applicable recommendations to reduce transmission.

As a clinical reference, the CDC states that vaccination may be delayed for up to three months from the onset of symptoms or from the positive test if the infection was asymptomatic. This is an option rather than a mandatory waiting period.

The timing may vary according to:

• The child’s risk of severe disease
• The child’s immune status
• Local levels of viral circulation
• The presence of vulnerable family members
• The pediatrician’s recommendation

Families in Mexico should follow current national and local medical guidance.

Some children may experience:

• Pain, redness, or swelling at the injection site
• Tiredness
• Headache
• Muscle or joint pain
• Chills
• Fever
• Irritability or sleepiness in younger children

These reactions are generally mild or moderate and usually improve within one to three days.

Medication should not routinely be given before vaccination solely to prevent possible side effects unless a healthcare professional has recommended it.

Seek medical care if the child develops difficulty breathing, swelling of the face or throat, widespread hives, severe weakness, or any reaction that appears serious or continues to worsen.

Myocarditis is inflammation of the heart muscle, while pericarditis affects the tissue surrounding the heart. Both conditions have been reported infrequently after messenger RNA vaccines, most often in adolescent and young adult males.

The FDA reported that the observed risk has been highest among males ages 12 to 24, with symptoms usually appearing during the first week after vaccination. This risk should be discussed openly and considered alongside the child’s individual risk of complications from COVID-19.

Seek prompt medical attention if a child develops:

• Chest pain or pressure
• Shortness of breath
• Palpitations
• A rapid or irregular heartbeat
• Fainting or unusual weakness

Tell the pediatrician about any previous episode of myocarditis or pericarditis before the child receives another dose.

A medical assessment is especially important when the child:

• Has a chronic health condition
• Receives chemotherapy, corticosteroids, or immunosuppressive medication
• Has received an organ transplant
• Experienced a severe allergic reaction to a previous dose
• Has a history of myocarditis or pericarditis
• Started but did not complete a previous vaccination schedule
• Received vaccines from different manufacturers
• Recently had COVID-19
• Lives with an immunocompromised person
• Has an incomplete or uncertain vaccination history

The consultation gives families an opportunity to review the child’s medical history and discuss the potential benefits and risks clearly. Every child’s situation is different.

If you live in Los Cabos, confirm which vaccines are currently available, the ages for which they are authorized, and whether your child belongs to one of the groups included in the current vaccination campaign.

A pediatric appointment is also an opportunity to review your child’s complete immunization record. Routine vaccines against measles, whooping cough, influenza, and other preventable diseases remain essential and should not be overlooked while considering COVID-19 vaccination.

Are you unsure whether your child needs an updated COVID-19 vaccine? Our specialists can review your child’s medical history, previous vaccinations, prior infections, and individual risk factors to provide a personalized recommendation.

Schedule an appointment with our specialists in Los Cabos via WhatsApp:
📲 +52 (624) 151 0693

Vaccine eligibility, availability, and the appropriate schedule must be confirmed according to Mexico’s current health guidelines.

Recommendations depend on current health policies, the child’s age, and individual risk factors. In 2026, families should discuss their child’s situation with a pediatrician and consult the latest guidance from Mexico’s Ministry of Health.

Not necessarily. The expected benefit is usually greater in children with conditions associated with severe COVID-19, such as immunosuppression, obesity, diabetes, heart disease, or chronic lung disease.

The number of doses depends on the child’s age, previous vaccinations, date of the most recent dose, immune status, and the vaccine currently authorized and available. A universal schedule should not be used without reviewing this information.

Yes. A previous infection does not prevent future vaccination. A pediatrician can recommend an appropriate time after recovery based on the child’s risk and current local guidance.

Not as a general rule. The child should have recovered from the acute illness and follow current measures to prevent transmission, but a negative test is not a universal requirement.

In many circumstances, vaccines can be administered during the same visit. The healthcare professional should first review the child’s age, medical history, and outstanding routine vaccinations.

The most common reactions include injection-site pain, tiredness, headache, muscle aches, chills, and fever. They usually resolve within one to three days.

Difficulty breathing, swelling of the face or throat, chest pain, shortness of breath, palpitations, fainting, or any severe or worsening reaction requires prompt medical evaluation.